awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36161550-16B0C86C-88F8-4D88-B286-DDE1142C570D
Q36161550-16B0C86C-88F8-4D88-B286-DDE1142C570D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36161550-16B0C86C-88F8-4D88-B286-DDE1142C570D
A Phase II Clinical Trial of CPI-613 in Patients with Relapsed or Refractory Small Cell Lung Carcinoma
P2860
Q36161550-16B0C86C-88F8-4D88-B286-DDE1142C570D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36161550-16B0C86C-88F8-4D88-B286-DDE1142C570D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ea75262393af7982041f63411b21bf74dd49721b
P2860
A phase I study of the first-in-class antimitochondrial metabolism agent, CPI-613, in patients with advanced hematologic malignancies.